2023, 'Priorities in Biobanking Research: A Report on the 2021 ISBER Round Table', Biopreservation and Biobanking, 21, pp. 111 - 113, http://dx.doi.org/10.1089/bio.2021.0178
Journal articles | 2022
2022, 'Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes', Clinical Cancer Research, 28, pp. 5383 - 5395, http://dx.doi.org/10.1158/1078-0432.CCR-22-1206
2022, 'MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma', Virchows Archiv, 480, pp. 855 - 871, http://dx.doi.org/10.1007/s00428-021-03232-0
Journal articles | 2021
2021, 'Moving with the Times: The Health Science Alliance (HSA) Biobank, Pathway to Sustainability', Biomarker Insights, 16, pp. 1 - 10, http://dx.doi.org/10.1177/11772719211005745
Journal articles | 2015
Scott GM; Hettiaratchi A; Salisbury E; Ward RL; Hawkins NJ, 2015, 'Institutional biobanking: An integral part of contemporary pathology practice', Pathology, 47, pp. 4 - 6, http://dx.doi.org/10.1097/PAT.0000000000000185
Journal articles | 2008
Jackson NE; Wang HW; Bryant KJ; McNeil HP; Husain A; Liu K; Tedla N; Thomas PS; King GC; Hettiaratchi A; Cairns J; Hunt JE, 2008, 'Alternate mRNA splicing in multiple human tryptase genes is predicted to regulate tetramer formation.', The Journal of Biological Chemistry, 283, pp. 34178 - 34187, http://dx.doi.org/10.1074/jbc.M807553200
2007, 'The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer', British Journal of Cancer, 96, pp. 783 - 792, http://dx.doi.org/10.1038/sj.bjc.6603630
2002, 'Insulin-like growth factor-II/mannose 6-phosphate receptor overexpression reduces growth of choriocarcinoma cells in vitro and in vivo.', Endocrinology, 143, pp. 4287 - 4294, http://dx.doi.org/10.1210/en.2002-220548
1995, 'Multidrug resistance plasmid pSK108 from coagulase-negative staphylococci; relationships to Staphylococcus aureus qacC plasmids.', Plasmid, 34, pp. 62 - 67, http://dx.doi.org/10.1006/plas.1995.1034
Other | 2023
2023, Data from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes, , http://dx.doi.org/10.1158/1078-0432.c.6532782
Other | 2023
2023, Data from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes, , http://dx.doi.org/10.1158/1078-0432.c.6532782.v1
Other | 2023
2023, Supplementary Figures S1-S13 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes, , http://dx.doi.org/10.1158/1078-0432.22488654
Other | 2023
2023, Supplementary Figures S1-S13 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes, , http://dx.doi.org/10.1158/1078-0432.22488654.v1
Other | 2023
2023, Supplementary Methods 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes, , http://dx.doi.org/10.1158/1078-0432.22488651
Other | 2023
2023, Supplementary Methods 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes, , http://dx.doi.org/10.1158/1078-0432.22488651.v1
Other | 2023
2023, Supplementary Tables S1-S11 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes, , http://dx.doi.org/10.1158/1078-0432.22488645
Other | 2023
2023, Supplementary Tables S1-S11 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes, , http://dx.doi.org/10.1158/1078-0432.22488645.v1
Conference Abstracts | 2014
Meagher NS; Scott G; Hettiaratchi A; Schwensen J; Jonnagaddala J; Caruso L; Ward RL; Crowe P; Salisbury E; Liauw W; others , 2014, 'Two years, fifteen hundred consents and counting. Integrating the HSA Biobank within routine clinical practice within the SESLHD.', in Innovations in Cancer Treatment and Care, Sydney, Australia, 17 October 2014.